Insider Trading25 Jun 2026, 05:10 pm
Brawn Biotech Closes Trading Window for Q2 FY27
AI Summary
Brawn Biotech Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in effect from July 1, 2026, until 48 hours after the declaration of the Un-Audited Financial Results for the quarter ended June 30, 2026. The company has advised insiders not to trade in its securities during this period. The exact date of the board meeting to consider these results will be communicated later.
Key Highlights
- Trading window closed for Q2 FY27 results announcement.
- Effective from July 1, 2026, until results are declared.
- Insiders and relatives are restricted from trading.
- Board meeting date for results declaration to be announced.
Price Impact
More from BRAWN